Correlation of symptomatic improvements with functional improvements and patient-reported outcomes in adults with attention-deficit/hyperactivity disorder treated with OROS methylphenidate

By Rösler Michael  

World Journal of Biological Psychiatry, Vol. 14, Iss. 4, 2013-05 ,pp. : 282-290

Informa Healthcare

Access to resources Recommend Favorite

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

By Rösler Michael   Fischer Roland   Ammer Richard   Ose Claudia   Retz Wolfgang  

European Archives of Psychiatry and Clinical Neuroscience, Vol. 259, Iss. 2, 2009-02 ,pp. : 120-129

Springer Publishing Company

Access to resources Recommend Favorite

Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) topography predicts treatment response to methylphenidate

By Sangal J.M.   Sangal R.B.  

Clinical Neurophysiology, Vol. 115, Iss. 1, 2004-01 ,pp. : 188-193

Elsevier

Access to resources Recommend Favorite

Response Inhibition in Adults with Autism Spectrum Disorder Compared to Attention Deficit/Hyperactivity Disorder

By Johnston Kate   Madden Anya   Bramham Jessica   Russell Ailsa  

Journal of Autism and Developmental Disorders, Vol. 41, Iss. 7, 2011-07 ,pp. : 903-912

Springer Publishing Company

Access to resources Recommend Favorite

The influence of working memory load on response inhibition in children with attention-deficit/hyperactivity disorder or reading disorder

By Van De Voorde Séverine   Roeyers Herbert   Verté Sylvie   Wiersema Jan Roelf  

Journal of Clinical and Experimental Neuropsychology (Neuropsychology, Developm, Vol. 33, Iss. 7, 2011-08 ,pp. : 753-764

Routledge Ltd

Access to resources Recommend Favorite